GT Biopharma, Inc. (GTBP) financial statements (2023 and earlier)

Company profile

Business Address 8000 MARINA BLVD
BRISBANE, CA 94005
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:32,0005,297286057619
Cash and cash equivalents9,2185,297286057619
Short-term investments23,011     
Other undisclosed cash, cash equivalents, and short-term investments(229)     
Prepaid expense19036424630 2
Other undisclosed current assets(21)     
Total current assets:32,1695,6612749057621
Noncurrent Assets
Property, plant and equipment   3564
Intangible assets, net (including goodwill), including:   25,262253,777 
Other undisclosed intangible assets, net (including goodwill)   25,262253,777 
Deposits noncurrent assets  12129 
Other undisclosed noncurrent assets  110   
Total noncurrent assets:  12225,309253,7924
TOTAL ASSETS:32,1695,66139625,399254,36825
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities10,0908,3776,3483,2172,6486,119
Accounts payable8,1892,2431,9401,7622,5462,100
Accrued liabilities1,9011,2962,3791,455102219
Interest and dividends payable 4,8382,029  3,800
Debt3126,30313,20710,673 889
Deferred rent credit   8
Derivative instruments and hedges, liabilities138383    
Due to related parties   100  
Other undisclosed current liabilities 31151313111,941
Total current liabilities:10,25935,09419,70614,0292,67918,949
Noncurrent Liabilities
Total liabilities:10,25935,09419,70614,0292,67918,949
Stockholders' equity
Stockholders' equity attributable to parent, including:21,910(29,433)(19,310)11,370251,689(18,924)
Preferred stock 3    
Common stock325270515031
Additional paid in capital674,348566,309548,118540,171519,702105,860
Accumulated deficit(653,584)(595,628)(567,332)(528,685)(267,896)(124,649)
Other undisclosed stockholders' equity attributable to parent1,114(169)(166)(167)(167)(166)
Total stockholders' equity:21,910(29,433)(19,310)11,370251,689(18,924)
TOTAL LIABILITIES AND EQUITY:32,1695,66139625,399254,36825

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues
(gain on Disposition of Assets for Financial Service Operations)
31,979     
Gross profit:31,979     
Operating expenses(57,515)(6,764)(16,056)(250,069)(135,570)(9,374)
Other undisclosed operating income (loss)(31,979)13,528    
Operating income (loss):(57,515)6,764(16,056)(250,069)(135,570)(9,374)
Nonoperating income (expense)(498)21,532(22,591)(9,117)(7,677)19,142
Investment income, nonoperating 12,598(4,599)(228,515)  
Interest and debt expense 3,003(2,128)(9,117)(8,602)(6,555)
Income (loss) from continuing operations before equity method investments, income taxes:(58,013)31,299(40,775)(268,303)(151,849)3,213
Other undisclosed income from continuing operations before income taxes  2,1289,1178,6026,555
Net income (loss):(58,013)31,299(38,647)(259,186)(143,247)9,768
Other undisclosed net loss attributable to parent (59,595)    
Net income (loss) available to common stockholders, diluted:(58,013)(28,296)(38,647)(259,186)(143,247)9,768

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net income (loss):(58,013)31,299(38,647)(259,186)(143,247)9,768
Comprehensive income (loss), net of tax, attributable to parent:(58,013)31,299(38,647)(259,186)(143,247)9,768

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: